AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Kotloff, KL Sztein, MB Wasserman, SS Losonsky, GA DiLorenzo, SC Walker, RI
Citation: Kl. Kotloff et al., Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection, INFEC IMMUN, 69(6), 2001, pp. 3581-3590

Authors: Kotloff, KL Wasserman, SS Losonsky, GA Thomas, W Nichols, R Edelman, R Bridwell, M Monath, TP
Citation: Kl. Kotloff et al., Safety and immunogenicity of increasing doses of a Clostridium difficile toroid vaccine administered to healthy adults, INFEC IMMUN, 69(2), 2001, pp. 988-995

Authors: Samandari, T Kotloff, KL Losonsky, GA Picking, WD Sansonetti, PJ Levine, MM Sztein, MB
Citation: T. Samandari et al., Production of IFN-y and IL-10 to Shigella invasions by mononuclear cells from volunteers orally inoculated with a shiga toxin-deleted Shigella dysenteriae type 1 strain (vol 164, pg 2221, 2000), J IMMUNOL, 165(8), 2000, pp. 4756-4756

Authors: Samandari, T Kotloff, KL Losonsky, GA Picking, WD Sansonetti, PJ Levine, MM Sztein, MB
Citation: T. Samandari et al., Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain, J IMMUNOL, 164(4), 2000, pp. 2221-2232

Authors: Kotloff, KL Noriega, FR Samandari, T Sztein, MB Losonsky, GA Nataro, JP Picking, WD Barry, EM Levine, MM
Citation: Kl. Kotloff et al., Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans, INFEC IMMUN, 68(3), 2000, pp. 1034-1039

Authors: Tacket, CO Sztein, MB Wasserman, SS Losonsky, G Kotloff, KL Wyant, TL Nataro, JP Edelman, R Perry, J Bedford, P Brown, D Chatfield, S Dougan, G Levine, MM
Citation: Co. Tacket et al., Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in US volunteers, INFEC IMMUN, 68(3), 2000, pp. 1196-1201

Authors: Strickler, HD Viscidi, R Escoffery, C Rattray, C Kotloff, KL Goldberg, J Manns, A Rabkin, C Daniel, R Hanchard, B Brown, C Hutchinson, M Zanizer, D Palefsky, J Burk, RD Cranston, B Clayman, B Shah, KV
Citation: Hd. Strickler et al., Adeno-associated virus and development of cervical neoplasia, J MED VIROL, 59(1), 1999, pp. 60-65

Authors: Kotloff, KL Winickoff, JP Ivanoff, B Clemens, JD Swerdlow, DL Sansonetti, PJ Adak, GK Levine, MM
Citation: Kl. Kotloff et al., Global burden of Shigella infections: implications for vaccine developmentand implementation of control strategies, B WHO, 77(8), 1999, pp. 651-666

Authors: Michetti, P Kreiss, C Kotloff, KL Porta, N Blanco, JL Bachmann, D Herranz, M Saldinger, PF Corthesy-Theulaz, I Losonsky, G Nichols, R Simon, J Stolte, M Ackerman, S Monath, TP Blum, AL
Citation: P. Michetti et al., Oral immunization with urease and Escherichia coli heat-labile enterotoxinis safe and immunogenic in Helicobacter pylori-infected adults, GASTROENTY, 116(4), 1999, pp. 804-812
Risultati: 1-9 |